Finally, miRNA-204-5p was up-regulated in the OCP group; it promotes apoptosis by targeting BCL2 in prostate cells [72] and is a tumor suppressor in breast cancer [73], and lower levels predict lymph node negative status in endometrial cancers [74]. Here, BCL2 is linked to endometrial cancer.